ASX:ILAPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
Island Pharmaceuticals Ltd
$0.390
Day Range
$0.385 – $0.393
52 Week Range
$0.160 – $0.630
Volume
0.00
Avg Volume (10D)
154.89K
Market Cap
$115.41M
Price Chart
Market Statistics
Open$0.390
Previous Close$0.390
Day High$0.393
Day Low$0.385
52 Week High$0.630
52 Week Low$0.160
Valuation
Market Cap115.41M
Shares Outstanding295.92M
Price to Book14.66
Trading Activity
Volume0.00
Value Traded0.00
Bid$0.390 × 5,101
Ask$0.390 × 29,783
Performance
1 Day1.30%
5 Day-2.50%
13 Week5.41%
52 Week129.41%
YTD-9.30%
Technical Indicators
RSI (14)45.73
50-Day SMA$0.396
200-Day SMA$0.411
Latest News
Biotechnology
Island Pharmaceuticals Expands USAMRIID Agreement for Galidesivir Marburg Study
Island Pharmaceuticals expands USAMRIID CRADA to dose-optimise Galidesivir Marburg study; trials start next quarter; topline results H2 2026, a major milestone.
Biotechnology
Island Pharmaceuticals Strengthens Biodefence Engagement for Galidesivir Advancement
Island Pharmaceuticals strengthens US biodefence push with new adviser Mark Herzog, MC2 roles, and Galidesivir progress toward FDA Animal Rule trials.
Biotechnology
Island Pharma Expands Antiviral Pipeline with Burnet Institute Collaboration and NHMRC Funding
Island Pharma expands antiviral pipeline with Burnet Institute; NHMRC grant of over $780k to back ISLA-101, accelerating Galidesivir MVD program.
Biotechnology
Island Pharma Partners with USAMRIID and Geneva Foundation for Galidesivir under FDA Animal Rule
Island Pharma signs a 3-year CRADA with USAMRIID and Geneva Foundation to fast-track Galidesivir for Marburg under FDA Animal Rule, eyeing NDA.